InvestorsHub Logo
Followers 275
Posts 32410
Boards Moderated 0
Alias Born 11/14/2013

Re: norisknorewards post# 683943

Monday, 04/08/2024 1:44:13 AM

Monday, April 08, 2024 1:44:13 AM

Post# of 687938
Right, as an adjuvant.

https://www.cancerresearch.org/cancer-types/skin-cancer

Poly ICLC (Hiltonol®): an immune adjuvant targeting the Toll-like receptor 3 (TLR3) pathway; approved for subsets of patients with squamous cell carcinoma.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News